Abstracts and Awards – BCVS Scientific Sessions 2024

BCVS 2023 Abstract Categories

Abstract submission is now closed.

  1. Cardiac Regeneration, Stem Cells and Tissue Engineering
  2. Cardio-immunology and Inflammation
  3. Cardio-oncology
  4. Cardiovascular Therapeutics - NEW!
  5. Cell Death Mechanisms, Apoptosis, Necrosis and Autophagy
  6. Clinical/Translational Research
  7. COVID 19 in the Cardiovascular System
  8. Excitation-Contraction Coupling and Ion Channels and Arrhythmias
  9. Extracellular Vesicles and Exosome Biology - NEW!
  10. Genetics and Genomics of Cardiovascular Disease
  11. Human Cellular Models of Disease 
  12. Inflammation, Thrombosis and Vascular Biology
  13. Mechanisms of Cardiac Remodeling, Hypertrophy and Failure
  14. Mechanisms of Heart Failure Preserved Ejection Fraction
  15. Mechanisms of Myocardial Fibrosis
  16. Mitochondria and Metabolism
  17. Myocardial Ischemia, Oxidative Stress, and Cardioprotection
  18. RNA and Cellular Regulation
  19. Sarcomeric Function and Contractility
  20. Sex-based Differences in Heart Disease - NEW!
  21. Signal Transduction Pathways
  22. Systems Approach to Cardiovascular Biology
  23. Transcriptional and Epigenetic Regulation of Gene Expression
Download the FINAL Abstract Categories (PDF)

Important Message to Abstract Submitters

The AHA has moved to a single sign-on process for submitting abstracts and disclosures through our website, Professional Heart Daily.

  • Abstract submitters must have a username and password on Professional Heart Daily to complete their abstract submission when submitting to any AHA scientific meeting.

  • If you do not remember your Professional Heart Daily login information or need to update your personal profile, do not create a new account. Please reach out to AHA Customer Service for assistance:

    AHA Customer Service
    (888) 242-2453 (Inside U.S.)
    (214) 570-5935 (Outside U.S.)
    Email: [email protected]

    Hours of Operation:
    Monday-Friday, 8 a.m. – 5 p.m. CT

  • The AHA is now required to collect financial disclosures from all abstract submitting authors and co-authors.
    • As the submitting author, please be prepared to provide all co-author emails.
    • Co-authors without a complete disclosure will receive separate correspondence to submit this information.